Statistics for Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial
Total visits
| views | |
|---|---|
| Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial | 133 |
Total visits per month
| views | |
|---|---|
| May 2024 | 0 |
| June 2024 | 0 |
| July 2024 | 0 |
| August 2024 | 0 |
| September 2024 | 0 |
| October 2024 | 0 |
| November 2024 | 0 |
File Visits
| views | |
|---|---|
| bmj.c3493.full.pdf | 105 |
Top country views
| views | |
|---|---|
| United States | 94 |
| Germany | 3 |
| United Kingdom | 3 |
| Canada | 2 |
| Ukraine | 2 |
| Vietnam | 2 |
| China | 1 |
| Malaysia | 1 |
| Sweden | 1 |
Top city views
| views | |
|---|---|
| Wilmington | 41 |
| Fairfield | 11 |
| Houston | 9 |
| Ann Arbor | 5 |
| Cambridge | 4 |
| Jacksonville | 4 |
| Kiez | 3 |
| San Francisco | 3 |
| Dong Ket | 2 |
| Kiev | 2 |
| Toronto | 2 |
| Baltimore | 1 |
| Beijing | 1 |
| Derby | 1 |
| Milpitas | 1 |
| Norwalk | 1 |
| Oakland | 1 |
| Seattle | 1 |
| Seremban | 1 |
| Stockholm | 1 |
| Warrington | 1 |
| Washington | 1 |